---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-023441"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:31:42.898772+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical Appoints Sarah Romano as CFO Effective April 1, 2025

## Summary
- Sarah Romano named CFO and Treasurer, effective April 1, 2025; succeeds prior CFO? Not disclosed.
- Base salary $435,000; target annual bonus 40%; receives stock option for 55,000 shares with 25% vesting at 1 year.
- Romano previously CFO of Entero Therapeutics (Nasdaq: ENTO) and Kiora Pharmaceuticals (Nasdaq: KPRX).
- Press release cites approaching first clinical use cases in 2025 as key milestone for financial strategy.

## SEC filing metadata
- accession: 0001213900-25-023441
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390025023441/0001213900-25-023441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390025023441/ea0234154-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-023441
- JSON: https://secwatch.observer/filing/0001213900-25-023441.json
- Plain text: https://secwatch.observer/filing/0001213900-25-023441.txt

## Key facts
- Executive change
  Sarah Romano was appointed as Chief Financial Officer and Treasurer at Vicarious Surgical Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Treasurer
  source text: On March 13, 2025, Vicarious Surgical Inc. (the “Company”) announced that Sarah Romano was appointed by the Board of Directors of the Company (the “Board”) as Chief Financial Officer and Treasurer of the Company, effective April 1, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812173/000121390025023441/0001213900-25-023441-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.